Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2941 AL 2955

Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers

Ferreira D, Jelic V, Cavallin L, Oeksengaard AR, Snaedal J, Høgh P, Andersen BB, Naik M, Engedal K, Westman E, Wahlund LO.

Dement Geriatr Cogn Disord. 2016;42(1-2):80-92. doi: 10.1159/000448394. Epub 2016 Sep 6.

The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease

Clark LF, Kodadek T.

ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14.

Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review

Chiam JT, Dobson RJ, Kiddle SJ, Sattlecker M.

J Alzheimers Dis. 2015;43(1):303-14. doi: 10.3233/JAD-140816.

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation

Shi M, Movius J, Dator R, Aro P, Zhao Y, Pan C, Lin X, Bammler TK, Stewart T, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Zhang J.

Mol Cell Proteomics. 2015 Mar;14(3):544-55. doi: 10.1074/mcp.M114.040576. Epub 2015 Jan 2.

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Dursun E, Gezen-Ak D, Hanağası H, Bilgiç B, Lohmann E, Ertan S, Atasoy İL, Alaylıoğlu M, Araz ÖS, Önal B, Gündüz A, Apaydın H, Kızıltan G, Ulutin T, Gürvit H, Yılmazer S.

J Neuroimmunol. 2015 Jun 15;283:50-7. doi: 10.1016/j.jneuroim.2015.04.014. Epub 2015 Apr 25.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005.

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease

Gui Y, Liu H, Zhang L, Lv W, Hu X.

Oncotarget. 2015 Nov 10;6(35):37043-53. doi: 10.18632/oncotarget.6158.

Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease

Goldman JG, Aggarwal NT, Schroeder CD.

Neurodegener Dis Manag. 2015 Oct;5(5):425-43. doi: 10.2217/nmt.15.34. Epub 2015 Oct 30.

Alzheimer's and Parkinson's diseases: an environmental proteomic point of view

Demartini DR, Schilling LP, da Costa JC, Carlini CR.

J Proteomics. 2014 Jun 2;104:24-36. doi: 10.1016/j.jprot.2014.04.014. Epub 2014 Apr 18.

[Neuroepigenetics: Desoxyribonucleic acid methylation in Alzheimer's disease and other dementias]

Mendioroz Iriarte M, Pulido Fontes L, Méndez-López I.

Med Clin (Barc). 2015 May 21;144(10):457-64. doi: 10.1016/j.medcli.2014.03.023. Epub 2014 Jun 3.

Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration

Oeckl P, Steinacker P, von Arnim CA, Straub S, Nagl M, Feneberg E, Weishaupt JH, Ludolph AC, Otto M.

J Proteome Res. 2014 Nov 7;13(11):4518-25. doi: 10.1021/pr5006058. Epub 2014 Aug 13.

Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease

Meyer PM, Tiepolt S, Barthel H, Hesse S, Sabri O.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):376-86. Epub 2014 Nov 11.

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B.

Nat Rev Neurol. 2015 Jan;11(1):41-55. doi: 10.1038/nrneurol.2014.232. Epub 2014 Dec 16.

Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia

Olsson B, Hertze J, Ohlsson M, Nägga K, Höglund K, Basun H, Annas P, Lannfelt L, Andreasen N, Minthon L, Zetterberg H, Blennow K, Hansson O.

J Alzheimers Dis. 2013;34(3):673-9. doi: 10.3233/JAD-121384.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias